https://acpinternist.org/archives/2020/01/recalls-research-for-generic-drug-safety.htm. Image by AntonioGuillem. Probable carcinogens have been found in angiotensin-receptor blockers, but experts say generic drugs remain ... Choudhry. “Recent events
Researchers used the Drug Involved Mortality database from the National Center for Health Statistics, which tallied drug-related terms mentioned on every U.S.
The researchers wrote that the association of fluoroquinolone use with the aneurysm rate was consistent, suggesting a drug class risk among both healthy and unhealthy individuals and indicating that fluoroquinolones should
News coverage of drug-contaminated water samples in Philadelphia and 24 other U.S. ... Daughton and Ilene Sue Ruhoy. Drug Safety 2008; 31(12): 1069-1082. White House Office of National Drug Control Policy position statement.
The increase in exposures to and misuse of these medications in the U.S. may represent an unintended consequence of recent reductions in opioid prescribing for pain management, study authors said.
FDA Drug Safety Communication. FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin. ... Accessed on Sept. 14, 2016. FDA Drug Safety Communication. FDA revises warning regarding use of
opioid combination products, as appropriate) are inadequate or not tolerated, as well as providing dosing information with clearer instructions regarding patient monitoring and drug administration, according to an FDA news release. ... Details on these
A drug safety communication about over-the-counter acne products (including Proactiv, Neutrogena, MaxClarity, Oxy, Ambi, Aveeno, Clean & Clear) and the risk of rare but potentially life-threatening allergic reactions or ... The agency will, however,
However, the benefits of the drug class outweigh the risks for some serious bacterial infections, such as anthrax, plague, and bacterial pneumonia. ... In May, the agency issued a drug safety communication advising that fluoroquinolones should be used
But SGLT2 inhibitors have recently been linked to 20 cases of diabetic ketoacidosis (DKA), as noted in a May 15 drug safety communication from the FDA. ... start. A patient who knows you will update them as information accumulates is a partner in